Keyphrases
Chronic Pancreatitis
100%
Exocrine Pancreatic Insufficiency
100%
Pancreatic Enzymes
50%
Cross-sectional Observational Study
50%
Quality Management
50%
Crohn's Disease
50%
Adherence to Guidelines
50%
Infliximab Therapy
50%
Infliximab
50%
Enzyme Treatment
50%
Compound Heterozygous mutation
50%
Risk Association
50%
Copenhagen
50%
Single Center
50%
Risk Factors
50%
Hereditary Hemochromatosis
50%
Enzyme Replacement Therapy
40%
Pancreas
30%
Odds Ratio
30%
Centre Differences
20%
Undertreatment
20%
Type 1 Diabetes Mellitus (T1DM)
18%
Ferritin
16%
Scandinavian
15%
Confidence Interval
13%
Clinical Remission
12%
Biochemical Relapse
12%
Endoscopic Remission
12%
Current Smoking
10%
Alcohol Abuse
10%
Treatment Adherence
10%
Therapeutic Agents
10%
Pancreatic Enzyme Replacement Therapy
10%
Exocrine Function
10%
Gastroenterology
10%
Pancreatic Function
10%
Expert Center
10%
Inappropriate Treatment
10%
Exocrine Pancreatic Function
10%
Diagnostic Criteria
10%
Common Complications
10%
Guideline-concordant Treatment
10%
Undertreated
10%
Bile Duct Stenosis
10%
Patient Characteristics
10%
Fecal Elastase
10%
Evidence-based Guidelines
10%
Lipase
10%
Vitamin D Deficiency
10%
Etiology
10%
Medicine and Dentistry
Chronic Pancreatitis
100%
Exocrine Pancreatic Insufficiency
91%
Pancreas Enzyme
50%
Enzyme Therapy
50%
Observational Study
50%
Hemochromatosis
50%
Enzyme Replacement Therapy
41%
Odds Ratio
30%
Symptom
25%
Ferritin
16%
Pancreas Function
16%
Underweight
13%
Cholestasis
10%
Stenting
10%
Diabetes Mellitus
10%
Surgery
10%
Metacarpophalangeal Joint
8%
Elastase
8%
Libido Disorder
8%
Arthralgia
8%
Hypovitaminosis D
8%
Vitamin D Deficiency
8%
Patient Compliance
8%
Gastroenterology
8%
Transferrin Saturation
8%
Triacylglycerol Lipase
8%
Cardiomyopathy
8%
Diagnosis
8%
Insulin Dependent Diabetes Mellitus
8%
Liver Cirrhosis
8%
Multivariate Analysis
5%
Multivariate Logistic Regression Analysis
5%
Demography
5%
Common Bile Duct
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Pancreatitis
50%
Pancreas Enzyme
50%
Observational Study
50%
Infliximab
50%
Crohn's Disease
50%
Exocrine Pancreatic Insufficiency
41%
Replacement Therapy
41%
Remission
11%
Elastase
8%
Pancreatic Lipase
8%
Ethanol
8%
Hypovitaminosis D
8%
Underweight
8%
Vitamin D Deficiency
8%
Gastroenterology
8%
Placebo
5%
